CD4 and neoplasm: The H3K27M-reactive TCRs in the CSF were identified as central memory CD4+ T cells, which have previously been shown to be superior in controlling tumor growth both in vitro and in vivo because of their increased cytokine secretion and prolonged persistence relative to effector T cells (34).